Ernexa Therapeutics (ERNAW) FCF Payout Ratio (2010 - 2015)

Ernexa Therapeutics (ERNAW) has 4 years of FCF Payout Ratio data on file, last reported at 0.0 in Q4 2015.

• Quarterly FCF Payout Ratio fell 150.12% year-over-year to 0.0 in Q4 2015, while the trailing twelve-month figure through Sep 2019 was 0.01 (down 83.89% YoY) and the FY2015 annual result came in at 0.0, down 241.19% from the prior year.
• FCF Payout Ratio slipped to 0.0 in Q4 2015, from 0.01 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 0.01 in Q4 2014 to a low of 0.02 in Q4 2011.
• A 3-year average of 0.0 and a median of 0.0 in 2015 frame the typical range for FCF Payout Ratio.
• Annual changes were most pronounced in 2011 — FCF Payout Ratio sank 102.68% — and 2015, when it tumbled 150.12%.
• Tracing ERNAW's FCF Payout Ratio over 3 years: stood at 0.02 in 2011, then soared by 141.16% to 0.01 in 2014, then sank by 150.12% to 0.0 in 2015.
• The last three FCF Payout Ratio figures came in at 0.0 (Q4 2015), 0.01 (Q4 2014), and 0.02 (Q4 2011), per Business Quant data.